Cabaletta Bio, Inc. (CABA)
NASDAQ: CABA · Real-Time Price · USD
3.130
-0.060 (-1.88%)
At close: Aug 21, 2026, 4:00 PM EDT
3.180
+0.050 (1.60%)
After-hours: Aug 21, 2026, 7:30 PM EDT

Cabaletta Bio Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Income
-185.52-172.24-125.14-74.66-54.14-46.31
Net Income
-181.32-167.86-115.86-67.68-52.98-46.29
Earnings Per Share
-1.54-2.10-2.34-1.65-1.81-1.80
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
225.1133.6163.96241.25106.55122.22
Total Debt
25.7127.115.65.025.14-
Net Cash (Debt)
199.39106.5148.36236.23101.41122.22
Net Cash Growth
17.43%-28.21%-37.20%132.95%-17.03%12.48%
Net Cash Per Share
1.701.333.005.773.464.75

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-153.93-131.08-88.22-53.55-46.38-34.11
Capital Expenditures
-0.28-1.23-2.21-0.69-2.45-1.17
Free Cash Flow
-154.21-132.31-90.43-54.24-48.83-35.28
Free Cash Flow Growth
------

Valuation

Selected indicators aren't available for this stock.